Cannabis does appear to reduce headache and migraine symptoms for many users, but the evidence is still catching up to the enthusiasm. The strongest data comes from self-reported surveys and observational studies rather than large randomized trials, so headache specialists tend to describe cannabis as “promising but unproven.” What makes the topic interesting is not just anecdotal relief but a growing biological explanation for why cannabinoids and headache disorders might be connected at a deeper level than simple pain relief.
Why Cannabis Might Work Against Headaches
Your body produces its own cannabis-like chemicals called endocannabinoids, and these molecules play a role in regulating pain signals, inflammation, and the sensitivity of nerves that transmit headache pain. One of the most studied endocannabinoids, anandamide, has been found at lower-than-normal levels in the spinal fluid and blood of people with chronic migraine, and that reduction appears to be linked to heightened pain signaling in the spinal cord.1PubMed Central. Endocannabinoid System and Migraine Pain: An Update When you use cannabis, THC and CBD interact with the same receptors that anandamide normally binds to, which is likely why some people experience headache relief.
This observation led to a hypothesis called “clinical endocannabinoid deficiency,” which proposes that conditions like migraine, fibromyalgia, and irritable bowel syndrome share a common thread: the body isn’t producing enough of its own endocannabinoids. The idea was first formally proposed in 2006, and subsequent research has found supporting evidence, including those measurably lower anandamide levels in migraine patients.2PubMed Central. Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes Endocannabinoids and related compounds also seem to reduce pain signaling through the trigeminal nerve, the major nerve pathway responsible for migraine pain, suggesting that these compounds may target the specific wiring involved in headaches rather than just dulling pain generally.3PubMed. The endocannabinoid system and related lipids as potential targets for the treatment of migraine-related pain
What the Research Shows for Migraines
The most frequently cited numbers come from a large observational study of over 650 patients who tracked their migraine attacks while using inhaled cannabis. Roughly 88% reported a reduction in migraine severity over the course of 16 months, with the average severity rating dropping by about half on a ten-point scale.4PubMed Central. Efficacy and Safety of Medical Marijuana in Migraine Headache: A Systematic Review People who started with more severe attacks tended to see bigger drops. That’s an encouraging pattern, but it comes with important caveats: these were self-reports from people who chose to use cannabis, not a controlled comparison with a placebo or a standard migraine drug.
Comparisons with conventional migraine medications are still sparse. The reviews that have attempted to weigh cannabis against standard treatments like triptans or NSAIDs describe the results as mixed, with cannabis showing variable effectiveness and a real risk of side effects.5Current Opinion in Neurology. Cannabinoids in headache: helpful or harmful? That doesn’t mean cannabis is worse than available drugs, but it means no one can confidently say it’s better, either. The field is stuck in a gap where user experience runs far ahead of the kind of controlled evidence doctors usually rely on.
THC, CBD, and the Question of Which Matters More
Most people think of cannabis in terms of THC (the part that gets you high) and CBD (the part marketed for wellness without intoxication). For headaches, the limited trial data suggests the combination matters more than either one alone. In a randomized controlled trial comparing vaporized THC-dominant cannabis, a THC-plus-CBD formulation, and placebo for acute migraine, the combination of THC and CBD produced less euphoria, less feeling of being “high,” and less subjective cognitive impairment than THC alone.6PubMed Central. Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial CBD appears to blunt some of THC’s psychoactive effects at the receptor level, which could make the combination more practical for people who need to function during a migraine.
Mouse studies have also explored high-CBD-to-THC ratios and found that a 100:1 CBD-to-THC combination reduced light aversion and head-pain-related grimacing triggered by migraine-like stimuli, though it didn’t help with skin sensitivity around the face.7PubMed Central. Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice The takeaway from both animal and human data is that the ratio of THC to CBD likely matters, and the “right” ratio may depend on whether you’re trying to stop an acute attack or manage chronic headaches. The research here is genuinely early-stage, and anyone claiming a single ideal formulation is getting ahead of the science.
Nausea, Light Sensitivity, and Migraine’s Other Miseries
A migraine is rarely just a headache. Nausea, vomiting, sensitivity to light and sound, and difficulty concentrating can be as disabling as the pain itself. Cannabis may have an advantage over some standard painkillers in that it seems to address more than one symptom at once. A review of the evidence found that medical cannabis significantly reduced nausea and vomiting associated with migraine attacks after six months of use.8PubMed Central. Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence THC’s well-known anti-nausea properties, originally studied in the context of chemotherapy, likely play a role here. For someone who vomits during migraines and can’t keep oral medication down, an inhaled option has obvious practical appeal, regardless of what the controlled trials eventually show.
Cluster Headaches Are a Different Story
Cluster headaches are sometimes called “suicide headaches” because of their intensity, and people who suffer from them are understandably willing to try anything. But the data on cannabis for cluster headaches is less encouraging than for migraines. In a survey of 139 cluster headache patients, only about a quarter of those who tried cannabis reported any relief, while roughly the same proportion said cannabis actually provoked an attack.9PubMed. Use of cannabis among 139 cluster headache sufferers About half reported variable or uncertain effects.
One plausible explanation for why cannabis can trigger cluster headaches involves blood vessels. Cannabis raises heart rate and causes blood vessels to dilate, and cluster headache sufferers are unusually sensitive to dilation of blood vessels near the brain. This is consistent with the fact that alcohol, another vasodilator, reliably triggers cluster attacks, and supplemental oxygen, which constricts blood vessels, is one of the most effective acute treatments.10PubMed Central. The Use of Cannabis for Headache Disorders The researchers behind the cluster headache survey concluded that cannabis should not be recommended for this condition until controlled trials with specific cannabinoid compounds demonstrate a clearer benefit.
The Tolerance and Rebound Problem
One of the biggest concerns about using cannabis regularly for headaches is whether it creates the same kind of rebound cycle that other pain medications can. With conventional painkillers like triptans or combination analgesics, frequent use can paradoxically cause more headaches, a condition called medication overuse headache. A study comparing chronic migraine patients who used cannabis to those who did not found that medication overuse headache was present in about 81% of cannabis users, compared with 41% of non-users.11PubMed. Medication overuse headache in patients with chronic migraine using cannabis: A case-referent study The adjusted odds of having medication overuse headache were more than six times higher in cannabis users. That’s a striking difference, though it’s worth noting this was an observational study, meaning the people using cannabis may have had more treatment-resistant migraines to begin with.
Separately, a study tracking cannabis use sessions over time found some evidence of developing tolerance: later headache episodes showed less of a decrease in symptoms after cannabis use compared to earlier episodes, and users gradually increased their doses over time. On the other hand, the same study found no significant increase in baseline headache severity across sessions, which is at least somewhat reassuring. The authors noted that conventional medications cause medication overuse headache in about 15% of migraine patients, making the comparison complicated but worth tracking.
Gender Differences in Response
An unexpected finding from the research is that men and women may respond quite differently to cannabis for headaches. In one study, men reported larger reductions in headache severity after using cannabis, while women were more likely to report that their headache got worse. More women than men experienced headache exacerbation, and more men than women experienced headache reduction.12The Journal of Pain. Short- and Long-Term Effects of Cannabis on Headache and Migraine This is consistent with broader pain research showing that smoked cannabis produces greater pain relief in men than in women for reasons that are still being worked out. Given that migraines disproportionately affect women, this is an uncomfortable finding that deserves more study.
Strain Preferences and What Terpenes Might Do
People who use cannabis for headaches often have strong opinions about which strains work best. A study analyzing strain preferences among patients using cannabis for migraine, headache, arthritis, and chronic pain found that hybrid strains were the most popular among migraine and headache groups. The most preferred strain in those groups was high in THC and low in CBD, with its dominant terpenes being beta-caryophyllene and beta-myrcene, both of which have anti-inflammatory and pain-relieving properties in laboratory studies.13PubMed Central. Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort Whether terpenes contribute meaningfully to headache relief in humans or whether they’re just markers of the THC content people are actually responding to remains an open question. The idea that the full chemical profile of a cannabis plant matters more than THC alone, sometimes called the “entourage effect,” is popular among patients and dispensaries but is far from settled science.
Synthetic Cannabinoids and Prescription Options
Not all cannabinoid treatments involve smoking a plant. Nabilone, a synthetic cannabinoid available by prescription in several countries, has been tested specifically for medication overuse headache, the rebound condition discussed earlier. In a small controlled trial, nabilone outperformed ibuprofen at reducing pain intensity and daily painkiller consumption. Nabilone was also the only treatment in that trial that reduced patients’ level of medication dependence (by about 41%) and improved quality of life. Side effects were uncommon, mild, and went away when the drug was stopped.14PubMed Central. Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial This is a single small trial, not the kind of evidence that rewrites treatment guidelines, but it’s one of the few controlled experiments in this space and it points in a positive direction.
Synthetic cannabinoids have the advantage of standardized dosing, which is one of the biggest practical problems with whole-plant cannabis. When you buy cannabis from a dispensary, the THC and CBD content can vary significantly even within the same labeled product. A synthetic compound removes that variability, making it easier for researchers to study and for doctors to prescribe with confidence. The trade-off is that a single-molecule drug may miss whatever benefit the full chemical profile of the plant provides, if such a benefit exists.
Adolescents and the Developing Brain
Headaches are common in teenagers, and as medical cannabis becomes more accessible, some adolescents and their parents are interested in trying it. Pediatric neurologists have reported increasing use of cannabis for chronic headaches in young patients, despite the fact that no well-controlled studies exist to guide dosing, safety, or effectiveness in this age group.15PubMed Central. A multi-centre, tolerability study of a cannabidiol-enriched Cannabis Herbal Extract for chronic headaches in adolescents: The CAN-CHA protocol The core concern is that cannabinoids may affect brain development in ways that aren’t apparent until years later. Research protocols for studying cannabis in adolescents require extensive informed consent that explicitly addresses these unknowns. Until controlled data exists, most headache specialists consider cannabis inappropriate for patients under 18, and the few clinical trials underway are focusing on CBD-enriched preparations to minimize psychoactive exposure.
A Long History, Rediscovered
Cannabis as a headache treatment isn’t a modern invention. After the drug was reintroduced to Western medicine in 1839, it was widely used for headache disorders for nearly a century before being made illegal in the United States in 1937. The list of physicians who endorsed it for headaches reads like a hall of fame of neurology: John Russell Reynolds (Queen Victoria’s personal physician), William Gowers (a founder of modern neurology), and Sir William Osler (often called the father of modern medicine) all prescribed or recommended cannabis for headache conditions. Dosing in that era typically involved alcohol-based extracts in the range of 16 to 32 milligrams, chosen to provide relief while minimizing intoxication. For prevention, these doses were given two to three times daily for weeks or months; for acute attacks, higher doses were taken as needed, and some physicians recommended smoking. The fact that the medical establishment spent a hundred years using cannabis for headaches before the regulatory landscape changed is a historical detail that often surprises people encountering this topic for the first time. It doesn’t prove efficacy by modern standards, but it does explain why researchers returned to the question once legal barriers began to lift.